Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-10-000025
Filing Date
2010-05-19
Accepted
2010-05-19 15:38:07
Documents
1
Period of Report
2010-05-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4379
  Complete submission text file 0000875320-10-000025.txt   6000
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address
SMITH IAN F (Reporting) CIK: 0001197032 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 10845154